Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Experimental models of neuromyelitis optica.
Composite end points to assess delay of disability progression by MS treatments.
Energy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis.
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
Multiple Sclerosis: Methods and Protocols. Preface.
[Animal model of neuromyelitis optica].
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.
Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.
Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
Objectification of psychogenic postural instability by trunk sway analysis.
A critical role for interleukin-1β in the progression of autoimmune diseases.
Systemic lupus erythematosus presented as extensive longitudinal myelitis.
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
Immunoadsorption in steroid-refractory multiple sclerosis.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
Upregulation of voltage-gated Ca(2+) channels in mouse astrocytes infected with Theiler's murine encephalomyelitis virus (TMEV).
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Differential modulation of the juxtaparanodal complex in Multiple Sclerosis.
Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Pages
« first
‹ previous
…
638
639
640
641
642
643
644
645
646
…
next ›
last »